<DOC>
	<DOCNO>NCT00885222</DOCNO>
	<brief_summary>The purpose study : 1 . To determine , context prospective clinical trial , whether stimulation parameter PD patient treat DBS , associate antidepressant effect . 2 . To determine whether antidepressant effect relate independent change motor feature PD . 3 . To establish computerized database include stimulation parameter clinical parameter PD patient treat DBS . 4 . To develop computer-assisted decision make protocol program DBS parameter depress non-depressed PD patient .</brief_summary>
	<brief_title>Antidepressant Effect Deep Brain Stimulation Parkinson 's Disease Patients</brief_title>
	<detailed_description>Depressive symptom PD patient major predictor prognosis quality life . Therefore , successful treatment depression crucial PD patient . Using deep brain stimulation antidepressant ( augment standard antidepressant ) could promise new direction . The hypothesis test current project treatment deep brain stimulation improve neurological psychiatric ( depressive ) symptom PD . It hypothesize improvement depressive symptom simple consequence improvement neurological status . Data open label study form basis planning large scale control trial depress PD patient exploratory study patient major depression PD . Today , program DBS base neurological evaluation motor feature PD . If hypothesis proven , i.e . parameter manipulation DBS affect mental feature PD , crucial establish valid database enable study effect . Moreover , detailed database basis development computer-assisted decision make protocol programming DBS . A novel decision make protocol maximize benefit DBS depress non-depressed PD patient .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Clinically definite PD treat / candidate treatment DBS ( patient advance idiopathic PD deem appropriate DBS surgery ) . 2 . Patients include study irrespective whether diagnosis major depression ( mild moderate severe MDD ) fulfil baseline . Patients without depression monitor study evidence treatment emergent depression . Patients depression monitor antidepressant effect stimulation change . 3 . Age 4075 year 4 . Male female . 5 . Competent willing give write informed consent . 1 . Significant suicidal risk [ Hamilton Depression scale item 3 ( suicide ) &gt; 2 ] . 2 . Comorbidity Psychotic Disorder , Bipolar Disorder , Post Traumatic Stress Disorder ( PTSD ) , Eating Disorder . 3 . Lifetime history substance alcohol dependence abuse precede 12 month 4 . Significant cognitive decline , measure Addenbrooke 's Cognitive Examination ( ACE ) Frontal Assessment Battery ( FAB ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Deep brain stimulation</keyword>
</DOC>